{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T15:59:47Z","timestamp":1768492787793,"version":"3.49.0"},"posted":{"date-parts":[[2021,5,4]]},"group-title":"Immunology","reference-count":36,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2021,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Assessment of T-cell immunity to the COVID-19 coronavirus requires reliable assays and is of great interest, given the uncertain longevity of the antibody response. Some recent reports have used immunodominant spike (S) antigenic peptides and anti-CD28 co-stimulation in varying combinations to assess T-cell immunity to SARS-CoV-2. These assays may cause T-cell hyperstimulation and could overestimate antiviral immunity in chronically immunosuppressed transplant recipients, who are predisposed to infections and vaccination failures. Here, we evaluate CD154-expressing T-cells induced by unselected S antigenic peptides in 204 subjects-103 COVID-19 patients and 101 healthy unexposed subjects. Subjects included 72 transplanted and 130 non-transplanted subjects. S-reactive CD154+T-cells co-express and can thus substitute for IFN\u03b3 (n=3). Assay reproducibility in a variety of conditions was acceptable with coefficient of variation of 2-10.6%. S-reactive CD154+T-cell frequencies were a) higher in 42 healthy unexposed transplant recipients who were sampled pre-pandemic, compared with 59 healthy non-transplanted subjects (p=0.02), b) lower in Tr COVID-19 patients compared with healthy transplant patients (p&lt;0.0001), c) lower in Tr patients with severe COVID-19 (p&lt;0.0001), or COVID-19 requiring hospitalization (p&lt;0.05), compared with healthy Tr recipients. S-reactive T-cells were not significantly different between the various COVID-19 disease categories in NT recipients. Among transplant recipients with COVID-19, cytomegalovirus co-infection occurred in 34%; further, CMV-specific T-cells (p&lt;0.001) and incidence of anti-receptor-binding-domain IgG (p=0.011) were lower compared with non-transplanted COVID-19 patients. Healthy unexposed transplant recipients exhibit pre-existing T-cell immunity to SARS-CoV-2. COVID-19 infection leads to impaired T-cell and antibody responses to SARS-CoV-2 and increased risk of CMV co-infection in transplant recipients.<\/jats:p>","DOI":"10.1101\/2021.05.03.442371","type":"posted-content","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T20:50:16Z","timestamp":1620161416000},"source":"Crossref","is-referenced-by-count":6,"title":["Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipients"],"prefix":"10.64898","author":[{"given":"Chethan","family":"Ashokkumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinayak","family":"Rohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander H","family":"Kroemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sohail","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Mazariegos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon W","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish","family":"Nadig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Almeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harmeet","family":"Dhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nada","family":"Yazigi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udeme","family":"Ekong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica M","family":"Betancourt-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kavitha","family":"Mukund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pradeep","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikhar","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Soltys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manasi S","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey","family":"Bond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajai","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mylarappa","family":"Ningappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianna","family":"Spishock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Sindhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha","family":"Atale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prabhakar","family":"Baliga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shankar","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Sindhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2021050603501331000_2021.05.03.442371v1.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.4385"},{"key":"2021050603501331000_2021.05.03.442371v1.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2011117"},{"key":"2021050603501331000_2021.05.03.442371v1.3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9113401"},{"key":"2021050603501331000_2021.05.03.442371v1.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022483"},{"key":"2021050603501331000_2021.05.03.442371v1.5","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2639-4"},{"key":"2021050603501331000_2021.05.03.442371v1.6","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)31604-4"},{"key":"2021050603501331000_2021.05.03.442371v1.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"2021050603501331000_2021.05.03.442371v1.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2035389"},{"key":"2021050603501331000_2021.05.03.442371v1.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028436"},{"issue":"3","key":"2021050603501331000_2021.05.03.442371v1.10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3201\/eid2703.204543","article-title":"Antibody Responses 8 Months after Asymptomatic or Mild SARS-CoV-2 Infection","volume":"27","year":"2021","journal-title":"Emerging Infectious Diseases"},{"key":"2021050603501331000_2021.05.03.442371v1.11","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf8891"},{"key":"2021050603501331000_2021.05.03.442371v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2598-9"},{"key":"2021050603501331000_2021.05.03.442371v1.13"},{"key":"2021050603501331000_2021.05.03.442371v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.08.017"},{"key":"2021050603501331000_2021.05.03.442371v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2550-z"},{"key":"2021050603501331000_2021.05.03.442371v1.16","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000188166.17324.60"},{"key":"2021050603501331000_2021.05.03.442371v1.17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143120"},{"key":"2021050603501331000_2021.05.03.442371v1.18","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13601"},{"key":"2021050603501331000_2021.05.03.442371v1.19","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15315"},{"key":"2021050603501331000_2021.05.03.442371v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2017.12.005"},{"key":"2021050603501331000_2021.05.03.442371v1.21","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001076"},{"issue":"RR-5","key":"2021050603501331000_2021.05.03.442371v1.22","first-page":"1","article-title":"IGRA Expert Committee, Centers for Disease Control and Prevention (CDC). Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010","volume":"59","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"2021050603501331000_2021.05.03.442371v1.23","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201501-0199OC"},{"key":"2021050603501331000_2021.05.03.442371v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/nm1293"},{"key":"2021050603501331000_2021.05.03.442371v1.25","unstructured":"FDA U.S. Food and Drug Administration. Recently-Approved Devices. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfhde\/hde.cfm?id=H130004"},{"key":"2021050603501331000_2021.05.03.442371v1.26","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000289"},{"key":"2021050603501331000_2021.05.03.442371v1.27","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","year":"2020","journal-title":"Cell"},{"key":"2021050603501331000_2021.05.03.442371v1.28","doi-asserted-by":"crossref","unstructured":"Agrati C , Sacchi A , Bordoni V , et al. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19). Cell Death Differ. 2020;1\u201312.","DOI":"10.1038\/s41418-020-0572-6"},{"issue":"6","key":"2021050603501331000_2021.05.03.442371v1.29","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cell.2020.08.001","article-title":"Severe COVID-19 is marked by a dysregulated myeloid cell compartment","volume":"182","year":"2020","journal-title":"Cell"},{"key":"2021050603501331000_2021.05.03.442371v1.30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1800695115"},{"key":"2021050603501331000_2021.05.03.442371v1.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.06.034"},{"key":"2021050603501331000_2021.05.03.442371v1.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2020.04.009"},{"key":"2021050603501331000_2021.05.03.442371v1.33","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/hvaa210"},{"key":"2021050603501331000_2021.05.03.442371v1.34","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2016.0125"},{"key":"2021050603501331000_2021.05.03.442371v1.35","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-16-0297"},{"key":"2021050603501331000_2021.05.03.442371v1.36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12150"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2021.05.03.442371","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:40:54Z","timestamp":1768441254000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2021.05.03.442371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":36,"URL":"https:\/\/doi.org\/10.1101\/2021.05.03.442371","relation":{},"subject":[],"published":{"date-parts":[[2021,5,4]]},"subtype":"preprint"}}